Enseval Launches Digital Loyalty Program

Press Release No. 041/KFCP-DIR/PR/X/20

Jakarta, 10 October 2020, PT Kalbe Farma Tbk (Kalbe) through one of its subsidiaries of Enseval, PT Emos Global Digital (EGD), in collaboration with PT Kara Santan Pertama (KARA) launched a Digital Loyalty Program called Kara Poin that shall provide a variety of benefits for the customer of Kara Coconut milk and Kara Nata de Coco. Kara Points is supported by Mosly as a digital loyalty program that is used to integrate the rewards and benefit in the form of points to customers under business-to-business (B2B) schemes who buy the product both online through Emos, or through offline distributors.

'Kalbe Group through Enseval, an integrated distribution and logistics services company in health field shall continue to develop excellent services, among which is by innovating in the technology fields in accordance with the development of digital technology 4.0,' said Handy Halim, Director of PT Emos Global Digital. 'EGD was selected as KARA's partner after a rigorous selection process and thorough considerations. EGD has numerous advantages that allows it to provide solutions in reaching out to customers,' continued Handy.

The Digital Loyalty Program will be used to process a transaction into the calculation of points, points redeeming movement, the presentation of catalogs, push notifications, banners and pop-up banners, TVC/survey on the purchase of Kara products that are made by the customers, and other future features. All verified transactions will be converted into a value that can be exchanged by the customer into electronic top up credit.

EGD is a company that develops a number of digital platforms for business-to-business (B2B) distribution of health products. Emos is a digital platform owned by EGD as order management to simplify the health product orders for the customers.

Whereas Mosly is the latest development from EGD that is to be used as a digital platform that can be utilized by business entities that wish to present a loyalty program for their customers. Mosly integrate transaction data B2B customers who are entitled to earn POINTS to be redeemed into various attractive prizes, with the purpose to improve loyalty of the customers.

Enseval at a glance
Enseval is one of the subsidiaries of Kalbe that is engaged in distribution and logistics, mainly for health products. With more than 46 years of experience as a distribution and logistics company for health products, Enseval has an ISO 9001: 2015 Certificate on Quality Management Systems for: warehousing and distribution, raw materials and consumer health products and certificates of Good Distribution Practice (GDP) . Enseval has also obtained certificate of Good Drug Distribution (CDOB) from BPOM for their headquarters and all of their branch offices. At present Enseval has 48 branches spread throughout Indonesia. Aside from being a distributor of medicinal products, Enseval also distributes medical devices, raw materials and consumer goods. Since 1994, Enseval has been listed at the Indonesia Stock Exchange, with ticker code: EPMT.

Kalbe at a glance
PT Kalbe Farma Tbk ('Kalbe') was established in 1966 and is one of the largest listed pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio: prescription medicines (Cefspan, Brainact, Broadced, etc.); health product division that handles over-the-counter medication (Promag, Mixagrip, Komix, Woods, Fatigon, etc.); multivitamins (Fatigon, H2, XonCe, Hevit-C, JossC1000, etc.); as well as supplement and ready-to-consume drinks (Hydro Coco, Extra Joss); nutrition division (ChilKid, Prenagen, Diabetasol, Zee, etc,); and distribution division. Kalbe now has more than 40 subsidiaries, 14 production facilities with international standards, and employs approximately 17,000 employees, spread in more than 76 branches throughout Indonesia. Since 1991, Kalbe is listed on the Indonesia Stock Exchange (IDX: KLBF).

-oOo-


Print
1Rate this article:
No rating
  • [Link]
Please login or register to post comments.

Attachments

  • Original document
  • Permalink

Disclaimer

PT Kalbe Farma Tbk published this content on 10 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2020 06:04:05 UTC